SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-08-021105
Filing Date
2008-04-01
Accepted
2008-04-01 16:29:56
Documents
1
Period of Report
2008-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 19155
  Complete submission text file 0001209191-08-021105.txt   21043
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Issuer) CIK: 0000010081 (see all company filings)

IRS No.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address
Business Address BARR LABORATORIES INC 300 CORPORATE DRIVE SUITE 10 BLAUVELT NY 10913 18002275227
BOGDA MICHAEL (Reporting) CIK: 0001237254 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09860 | Film No.: 08729763